Browse studies

Find your next paid study

27,293 recruiting studies available now

Newest first Highest paying

Phase 2

An Open-label, Multicenter Study to Assess the Effect of Zigakibart Treatment on Histologic, Circulating, and Excreted Markers of Kidney Disease and Dysfunction in Adult Patients With IgA Nephropathy.

The purpose of the study is to assess the effect of zigakibart on IgA nephropathy (IgAN) disease progression.

Immunoglobulin A Nephropathy (IgAN)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07146906

Double Lung Transplant REgistry Aimed for Lung-limited Malignancies (DREAM) - a Prospective Observational Registry Study for Patients Undergoing Lung Transplantation for Medically Refractory Cancers Confined to the Lungs

This is a prospective observational registration trial for patients who undergo lung transplantation for the treatment of the select groups of medically refrac…

Lung CancerBilateral CancerLung Transplant

Estimated

~$10 – $750

Actual pay is set by the research site.

Northwestern UniversityNCT05671887

Observational

Randomized Trial of Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening

The project will investigate the efficacy of a Veteran-peer-navigator-led decision coaching (PDC) program to promote Shared Decision Making (SDM) for prostate …

Prostate Cancer

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06549036

Phase 4

Personalized Analgesia Through Central Nervous System Engagement to Unlock Performance

The goal of this clinical trial is to examine the effects of duloxetine on walking ability and physical activity in patients with knee osteoarthritis. Research…

Knee Osteoarthritis (Knee OA)Chronic PainChronic Knee Pain

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Benedict AlterNCT07759336

Observational

Feasibility of Cue-based Treatment Intervention to Promote Cessation Among People Who Smoke Lightly (≤10 Cigarettes Per Day) or Non-daily

This study aims to test the feasibility and acceptability of a remotely delivered cue-based treatment intervention to promote smoking cessation among people wh…

Tobacco Use Disorder

Estimated

~$10 – $750

Actual pay is set by the research site.

Duke UniversityNCT07425119

Phase 3

CLEOPATTRA: Effects of NNC6019-0001 Versus Placebo on Cardiovascular Outcomes in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition cal…

Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Novo Nordisk A/SNCT07207811

Phase 3

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy

Patients with a bunion will have that repaired and then pain and rescue medicine use will be evaluated.

Postoperative PainBunion

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Cali Pharmaceuticals LLCNCT07490496

Phase 2

A Pilot Study to Estimate Early Clinical Efficacy Signals of a Glucagon-like Peptide 1 Receptor Agonist (GLP-1RA) Administration in Conjunction With Levonorgestrel Intrauterine Device (LNG-IUD) in Obese Patients With Endometrioid Intraepithelial Neoplasia

This study will explore the use of glucagon-like peptide 1 receptor agonist (GLP-1RA) used concurrently with levonorgestrel intrauterine device in patients wit…

Endometrioid Endometrial Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of FloridaNCT07107334

Observational

The Effects of AFO Heel Height and Stiffness on Gait

The proposed study evaluates the effect of ankle foot orthosis (AFO) heel height and stiffness on the forces and motion of the lower limb during over-ground wa…

Musculoskeletal InjuryMusculoskeletal DiseasesPeripheral Nervous System Diseases

Estimated

~$10 – $750

Actual pay is set by the research site.

University of IowaNCT04800484

Phase 1

LIGHTBEAM-U01 Substudy 01D: A Phase 1b/2 Substudy to Evaluate the Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors

Researchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refra…

Malignant Neoplasm

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07630974

Phase 2

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Induction and Maintenance Therapy With PALI-2108 in Participants With Moderately to Severely Active Ulcerative Colitis

The ASCENTRA-UC study is a phase 2 study testing PALI-2108 in patients with moderate to severe ulcerative colitis. Doses of drug will be compared against a pla…

Ulcerative Colitis (UC)Severe Ulcerative ColitisModerate Ulcerative Colitis

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Palisade BioNCT07845487

Phase 2

A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)

The study is intended to assess the safety and efficacy of perioperative treatment with Durvalumab in combination with Oleclumab, Monalizumab, or AZD0171 and p…

Non-small Cell Lung Cancer

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AstraZenecaNCT05061550